AnaptysBio Inc (ANAB)
26.58
+0.24
(+0.91%)
USD |
NASDAQ |
May 03, 16:00
26.57
-0.01
(-0.04%)
After-Hours: 20:00
AnaptysBio Net Income (TTM): -163.62M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -163.62M |
| September 30, 2023 | -147.82M |
| June 30, 2023 | -144.02M |
| March 31, 2023 | -136.72M |
| December 31, 2022 | -128.72M |
| September 30, 2022 | -134.85M |
| June 30, 2022 | -108.01M |
| March 31, 2022 | -75.89M |
| December 31, 2021 | -57.80M |
| September 30, 2021 | 8.388M |
| June 30, 2021 | -8.713M |
| March 31, 2021 | -29.83M |
| December 31, 2020 | -19.93M |
| September 30, 2020 | -73.84M |
| June 30, 2020 | -81.11M |
| March 31, 2020 | -83.52M |
| December 31, 2019 | -97.34M |
| September 30, 2019 | -94.07M |
| Date | Value |
|---|---|
| June 30, 2019 | -78.99M |
| March 31, 2019 | -68.65M |
| December 31, 2018 | -61.66M |
| September 30, 2018 | -51.52M |
| June 30, 2018 | -44.66M |
| March 31, 2018 | -33.72M |
| December 31, 2017 | -30.07M |
| September 30, 2017 | -27.79M |
| June 30, 2017 | -19.81M |
| March 31, 2017 | -14.81M |
| December 31, 2016 | -4.259M |
| September 30, 2016 | -3.193M |
| June 30, 2016 | -3.54M |
| March 31, 2016 | -5.917M |
| December 31, 2015 | -5.405M |
| September 30, 2015 | -1.391M |
| June 30, 2015 | 3.529M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-163.62M
Minimum
Dec 2023
8.388M
Maximum
Sep 2021
-87.18M
Average
-83.52M
Median
Mar 2020
Net Income (TTM) Benchmarks
| XOMA Corp | -40.83M |
| Fate Therapeutics Inc | -160.93M |
| Ocular Therapeutix Inc | -80.74M |
| Apellis Pharmaceuticals Inc | -528.63M |
| Sutro Biopharma Inc | -106.79M |